Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986482 as Monotherapy or Combination Therapy in Advanced Solid Tumors
NCT06697197Phase 2Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of BMS-986482 in solid tumor (advanced stage), sponsored by Bristol Myers Squibb. Started Feb 2025; status: recruiting.
02
Drugs
BMS-986482
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06697197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06697197.